Recruiting transgender men in the Southeastern United States for genital microbiome research: Lessons learned
Despite robust study inquiry by TGM, screening and enrollment challenges were faced including engagement by TGM not yet in care and specific study eligibility criteria. Excitement among TGM for research representation should be leveraged in future work by engaging transgender community stakeholders at the inception of study development, particularly regarding feasibility of study inclusion and exclusion criteria, as well as recruitment of TGM of color. These results also highlight the need for more clinical resources for prescribing gender-affirming hormone therapy, especially in the Southeastern US.
Authors
- Kristal J. Aaron (ORCID: https://orcid.org/0000-0002-9285-7321)
- Olivia T. Van Gerwen (ORCID: https://orcid.org/0000-0002-9362-6234)
- Jacob H. Elnaggar (ORCID: https://orcid.org/0000-0002-4696-6842)
- Christina A. Muzny (ORCID: https://orcid.org/0000-0002-4005-3858)
- Isaac C Eastlund
- Emma Sophia Kay (ORCID: https://orcid.org/0000-0002-8425-9196)
- Saralyn Richter
- Angela Pontius
- Joy H. Lewis (ORCID: https://orcid.org/0000-0003-1109-2281)
- Krishmita Siwakoti
- Keonte J. Graves (ORCID: https://orcid.org/0000-0002-8646-3801)
- Christopher M. Taylor (ORCID: https://orcid.org/0000-0002-7983-5275)
- Evelyn Toh (ORCID: https://orcid.org/0000-0003-2932-4060)
- Z. Alex Sherman
- Nicholas J. Van Wagoner
- Jay Wall
- Ben Rogers
Institutions
- University of Alabama at Birmingham (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1371/journal.pone.0308603
- Citations
- 4
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- Gilead Sciences
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Moderna
- School of Medicine, University of Alabama at Birmingham
- National Institute of Allergy and Infectious Diseases